Ignite Creation Date:
2024-05-05 @ 5:06 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00380653
Status:
COMPLETED
Last Update Posted:
2021-12-13
First Post:
2006-09-23
Brief Title:
Safety and Pharmacology Study of Sapacitabine to Treat Advanced Leukemias or Myelodysplastic Syndromes
Sponsor:
Cyclacel Pharmaceuticals Inc
Organization:
Cyclacel Pharmaceuticals Inc
Organization Data
Organization:
Cyclacel Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
CYC682-05-04
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cyclacel Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None